Eiger BioPharmaceuticals Inc (NASDAQ:EIGR)

1.42
Delayed Data
As of Jan 27
 -0.01 / -0.70%
Today’s Change
0.96
Today|||52-Week Range
10.02
+20.34%
Year-to-Date

Today’s Trading

Previous close1.43
Today’s open1.40
Day’s range1.38 - 1.43
Volume18,043
Average volume (3 months)753,464
Market cap$59.1M
Data as of 3:59pm ET, 01/27/2023

Growth & Valuation

Earnings growth (last year)+56.77%
Earnings growth (this year)-121.64%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales14.51
Price/Book0.67

Competitors

----
----
HEPAHepion Pharmaceutica...+0.02+1.92%
GNPXGenprex Inc0.000.00%
Data as of 3:59pm ET, 01/27/2023

Financials

Next reporting dateMarch 16, 2023
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$12.1M
Annual profit (last year)-$33.9M
Net profit margin-279.34%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Palo Alto, California

Forecasts